Proceedings of the National Academy of Sciences · 2011 · 81 citations · 25 references
Life SciencesCancer BiologyMolecular BiologyCell SignalingGene ExpressionSignal TransductionAntiviral ImmunityCytokine Receptor SignalingInflammatory SignalingInnate Immune Signaling PathwaysInterferon ResponsesOncogenic Signaling PathwaysAcute Myeloid Leukemia BiologyAntiviral Innate Immune SignalingAntiviral Innate SignalingCellular ProliferationProliferation PathwaysRig-i SignalingType I Interferon InductionViral Rna Recognition
RA-inducible gene I (RIG-I/DDX58) has been shown to activate IFN-β promoter stimulator 1 (IPS-1) on recognizing cytoplasmic viral RNAs. It is unclear how RIG-I functions within the IFN and/or RA signaling process in acute myeloid leukemia (AML) cells, however, where obvious RIG-I induction is observed. Here, we show that the RIG-I induction functionally contributes to IFN-α plus RA-triggered growth inhibition of AML cells. Interestingly, although RIG-I induction itself is under the regulation of STAT1, a major IFN intracellular signal mediator, under circumstances in which it does not stimulate IPS-1, it conversely augments STAT1 activation to induce IFN-stimulatory gene expression and inhibit leukemia cell proliferation. Thus, our results unveil a previously undescribed RIG-I activity in regulating the cellular proliferation of leukemia cells via STAT1, which is independent of its classic role of sensing viral invasion to trigger type I IFN transcription.
25
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Taro Kawai, Ken Takahashi, Shintaro Sato et al. · Nature Immunology · 2005 · 2.5K citations
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Etienne Meylan, Joseph Curran, Kay Hofmann et al. · Nature · 2005 · 2.4K citations · Full text